Meniscectomy News and Research RSS Feed - Meniscectomy News and Research

Active Implants receives IDE approval to conduct NUsurface Meniscus Implant trial for knee osteoarthritis

Active Implants receives IDE approval to conduct NUsurface Meniscus Implant trial for knee osteoarthritis

Active Implants, the technology leader in cushion-bearing orthopedics for treatment of osteoarthritis, today announced it has received Investigational Device Exemption (IDE) approval to conduct a pivotal clinical trial of the NUsurface® Meniscus Implant in patients with knee osteoarthritis. [More]
Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

Single stem cell injection after meniscus knee surgery may provide pain relief, aid in meniscus regrowth

​A single stem cell injection following meniscus knee surgery may provide pain relief and aid in meniscus regrowth, according to a novel study appearing in the January issue of the Journal of Bone and Joint Surgery (JBJS). [More]
FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

The Finnish Degenerative Meniscal Lesion Study (FIDELITY) compared surgical treatment of degenerative meniscal tears to placebo surgery. [More]
Omeros announces financial results for second quarter of 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013. [More]
NovoStitch suture passer now available for minimally invasive arthroscopic surgical procedures

NovoStitch suture passer now available for minimally invasive arthroscopic surgical procedures

Ceterix Orthopaedics, Inc. today announced commercial availability of the company's NovoStitch suture passer in the United States. The company's device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, during minimally invasive arthroscopic surgical procedures. [More]
Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Osteoarthritis associated genes: an interview with Professor Jonathan Tobias, University of Bristol

Joints are lined by articular cartilage, loss of which is one of the hallmarks of osteoarthritis. Articular cartilage is made up of a number of proteins, such as type II collagen. In rare forms of osteoarthritis, one of these structural proteins is defective as a result of a genetic mutation. [More]
Omeros completes enrollment in first of two OMS103HP Phase 3 meniscectomy trials

Omeros completes enrollment in first of two OMS103HP Phase 3 meniscectomy trials

Omeros Corporation today reported the completion of enrollment in the first of two planned Phase 3 clinical trials evaluating OMS103HP in patients undergoing arthroscopic partial meniscectomy surgery. [More]
NYU Langone experts to present at American Academy of Orthopaedic Surgeons annual meeting

NYU Langone experts to present at American Academy of Orthopaedic Surgeons annual meeting

Experts from the Department of Orthopaedic Surgery at NYU Langone Medical Center will present their latest research and clinical findings on diseases of the muscle, tendon, bone and joint at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), February 7-11 in San Francisco, California. [More]
Stem cell bandage human clinical trial for torn meniscal cartilage

Stem cell bandage human clinical trial for torn meniscal cartilage

The company behind a pioneering stem cell bandage, believed to be the world's first adult and autologous (patient's own) stem cell treatment designed to heal torn meniscal cartilage, can now take the technology to human clinical trials thanks to an investment from one of the UK's most successful entrepreneurs. [More]

Patients with motion limitations after knee surgery more likely to develop osteoarthritis

The onset of osteoarthritis may be related to a loss of knee motion after reconstructive ACL surgery, as noted in new research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego, California, July 7-10, 2011. [More]
Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs. [More]
Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported the outcome from its Phase 3 program evaluating OMS103HP in patients undergoing arthroscopic anterior cruciate ligament reconstruction surgery. [More]
New research: Incidence of PE after knee arthroscopy is 0.028%

New research: Incidence of PE after knee arthroscopy is 0.028%

Until now, the risk of pulmonary embolism after a knee arthroscopy has not been accurately defined and risk factors have only been suggested but not proven. New research, presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons shows that the incidence of symptomatic PE after outpatient knee arthroscopy is .028 percent. [More]
Omeros net loss for second-quarter 2010 increases to $7.8 million

Omeros net loss for second-quarter 2010 increases to $7.8 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010. [More]
Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Arthroscopic surgical repair of torn anterior cruciate ligaments (ACL) or meniscal cartilage injuries in the knee does not decrease the chances of developing osteoarthritis, according to a new study published in the online edition and August print issue of the journal Radiology. [More]
Omeros announces additional data from Phase 2 trial of OMS103HP for arthroscopic meniscectomy surgery

Omeros announces additional data from Phase 2 trial of OMS103HP for arthroscopic meniscectomy surgery

Omeros Corporation today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits. [More]
Positive results from Phase 2 clinical trial of OMS103HP

Positive results from Phase 2 clinical trial of OMS103HP

Omeros Corporation today announced that a Phase 2 clinical trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, demonstrated that patients treated with OMS103HP during arthroscopic knee meniscectomy surgery achieved statistically significant clinical benefits. [More]
Menaflex collagen meniscus implant performed in young veteran

Menaflex collagen meniscus implant performed in young veteran

ReGen Biologics (OTC: RGBO) (“ReGen” or “the company”) is pleased to report that Steven Tradonsky, MD of San Diego Sports Medicine recently treated a young veteran with the Menaflex collagen meniscus implant at the VA Medical Center in La Jolla, California. [More]
A stem cell bandage for your knee

A stem cell bandage for your knee

Building on his previous work, Hollander and his team, which included Dr Wael Kafienah and Dr John Tarlton, announced in 2005 they had, for the first time ever, successfully grown human cartilage from a patient's own bone marrow stem cells. [More]
Meniscal damage and joint malalignment predictors of cartilage loss

Meniscal damage and joint malalignment predictors of cartilage loss

Marked by cartilage and bone degradation, progressive knee osteoarthritis (OA) is believed to result in part from a combination of several local mechanical factors. Lack of joint stability, poor joint alignment and injuries to the disks of meniscal tissue that cushion the knee all affect load distribution and the toll to the vulnerable OA knee. [More]